
Roberto Miranda is a Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on the pathology and immunology of lymphoid neoplasia, particularly cutaneous T-cell lymphomas, anaplastic large cell lymphoma (ALCL), and leukemia. His recent work includes gene expression profiling identifying distinct targetable biology in ALCL, novel FGFR1 fusions in aggressive epidermotropic cytotoxic T-cell lymphoma treated with pemigatinib, and prognostic factors in large cell transformation of mycosis fungoides/Sezary syndrome. He has also contributed to clinical guidelines on breast implant–associated malignancies and lymphoma workshop reports on unusual pathologic presentations.
See moreHonors

Experiences

Education


Roberto Miranda
The University of Texas MD Anderson Cancer Center